Highest-materiality recent filing
Alignment Healthcare shareholders elect Class II directors, ratify auditor, approve say-on-pay
Three Class II directors elected: Jody Bilney, David Hodgson, Jacqueline Kosecoff, each with >108M 'for' votes.
Founder/CEO John Kao named Chairman; three new senior hires added
John Kao adds Chairman role; Joseph Konowiecki named Vice Chairman and EVP Corporate Affairs.
Alignment Healthcare Q1 revenue $1.24B (+33% YoY); raises full-year guidance
Total revenue $1.235B (+33.3% YoY); health plan membership ~284,800 (+30.9% YoY).
Selling Stockholder sold 13,167,733 shares of common stock via J.P. Morgan Securities LLC.
Alignment Healthcare beats Q4 and FY2025 guidance; FY2026 revenue guide $5.14-5.19B
Q4 revenue $1,012.8M (+44.4% YoY); FY2025 revenue $3,948.7M (+46.1% YoY).
Alignment Healthcare reports 31% membership growth to 275,300; guides 2026 membership 290k-296k
Health plan members as of Jan 1, 2026: ~275,300, up 31% year-over-year.
Alignment Healthcare beats Q3 guidance, revenue $993.7M (+43.5% YoY), raises FY outlook
Q3 revenue $993.7M (+43.5% YoY); health plan membership 229,600 (+25.9% YoY).
Alignment Healthcare reaffirms ~100% membership in 4+ Star Medicare Advantage plans for 2026/2027
Reaffirmed expectation that ~100% of its Medicare Advantage members will be in 4 Star or higher plans for rating year 2026/payment year 2027.
Alignment Healthcare Q2 revenue $1.015B (+49% YoY); raises full-year outlook
Total revenue of $1,015.3M, up 49.0% YoY; health plan membership 223,700, up 27.8% YoY.
Alignment Healthcare reports annual meeting results; all proposals pass
Margaret McCarthy, Mark McClellan, Robbert Vorhoff elected as Class I directors; McClellan received 81.4M for, 83.7M withhold.
Alignment Healthcare Q1 revenue up 47.5% to $926.9M; raises 2025 guidance; CFO transition
Q1 revenue $926.9M (+47.5% YoY); MA membership ~217,500 (+31.7% YoY).
Alignment Healthcare Chief Experience Officer Hakan Kardes resigns, effective immediately
Hakan Kardes, Chief Experience Officer, resigned on April 9, 2025, effective immediately.
Alignment Healthcare closes stockholder lawsuit; pays $950k in fees
Court closed the Maglione v. Konowiecki stockholder lawsuit on April 9, 2025, after company agreed to pay $950,000 in attorneys' fees.
Alignment Healthcare reports Q4 revenue $701M (+51% YoY); 2025 guidance $3.72-3.78B
Members 189,100 (+58.6% YoY) beating year-end expectations; 2025 guidance 227K-233K.
Alignment Healthcare sees 35% membership growth, 2025 outlook; promotes Dawn Maroney to President
Health plan membership as of Jan 1, 2025: 209,900, up 35% year-over-year.
Alignment Healthcare closes $330M convertible notes offering, repays $215M term loan
Sold $330M aggregate principal of 4.25% Convertible Senior Notes due 2029.
Alignment Healthcare issues $330M 4.25% convertible notes due 2029; proceeds to repay term loan
Issued $330M aggregate principal of 4.25% Convertible Senior Notes due 2029; net proceeds ~$321M.
Alignment Healthcare Q3 revenue up 51.6% YoY to $692.4M; raises membership and revenue guidance
Revenue $692.4M, up 51.6% YoY; health plan membership ~182,300, up 57.7% YoY.
Two directors resign from Alignment Healthcare board; Margolis enters consulting role
Jeffrey Margolis and Thomas Carella resigned from board effective Aug 13-14, 2024; board reduced from 11 to 9 directors.
Alignment Healthcare Q2 revenue up 47% to $681M; raises year-end guidance
Q2 revenue $681.3M (+47.3% YoY); health plan membership 175,100 (+56.1% YoY).
Alignment Healthcare borrows $50M Delayed Draw Term Loan to enhance balance sheet
On June 14, 2024, Alignment Health borrowed $50M principal (net $49.5M) under its existing term loan agreement with Oxford Finance.
Alignment Healthcare stockholders approve officer exculpation amendment, elect directors
Stockholders approved Certificate of Amendment to include officer exculpation provision as permitted by Delaware law; effective June 11, 2024.
Alignment Healthcare posts investor presentation; no material financial updates disclosed
Company posted investor presentation on website on June 5, 2024, for William Blair conference.
Alignment Healthcare Q1 revenue $628.6M (+43.1% YoY); membership up 50.5% to 165,100
Revenue ex-ACO REACH $627.6M, up 54.2% YoY; medical benefits ratio 90.9%.
Total revenue $1.82B for FY2023, up 27.2% YoY; health plan members 119,200 at year end, up 21.1% YoY.
Estimates approximately 155,500 Health Plan Members as of January 1, 2024, representing 44% year-over-year growth.
Chairman Konowiecki exits executive role; remains Board Chair, equity continues
Joseph Konowiecki ends executive role (strategic network & business development) on Dec 31, 2023; remains Board Chair.
Total revenue $456.7M (+26.7% YoY); health plan membership ~115,600 (+18% YoY).
Alignment Healthcare grants performance-based RSUs to executives; CEO target 2.18M shares
CEO John Kao receives threshold 1,088,667, target 2,177,333, max 3,266,000 PSUs tied to 2024 performance.
Appoints Hyong (Ken) Kim, M.D., as CMO; $560k salary, $2.5M RSU grant, target bonus 85%
Dr. Kim returns to Alignment Healthcare having previously served as CMO from June 2013 to March 2018.
Alignment Healthcare CMO Kumar to depart Oct 1; Dr. Furman expands clinical role, $500K base
Dr. Dinesh Kumar, Chief Medical & Operating Officer, to depart Oct 1, 2023 under mutual separation agreement.
Alignment Healthcare beats Q2 guidance; revenue up 26% to $462.4M, members +17%
Revenue $462.4M (+26.2% YoY); health plan premium revenue $424.7M (+21% YoY).
Alignment Healthcare General Counsel Richard Cross to retire Sept 1; severance terms disclosed
Richard Cross, SVP, General Counsel and Corporate Secretary, plans to retire effective September 1, 2023.
Alignment Healthcare annual meeting results: all proposals approved
Four Class II directors elected: Jody Bilney, David Hodgson, Jacqueline Kosecoff, Jeffrey Margolis (votes 129M-156M for).
Alignment Healthcare Q1 revenue $439.2M (+27.1% YoY), membership 109,700, beats guidance on all KPIs
Total revenue $439.2M, up 27.1% YoY; health plan premium revenue $399.7M (+20.8% YoY).
Alignment Healthcare reports 2022 revenue of $1.43B, up 23% YoY; guides 2023 revenue $1.705-1.73B
Q4 revenue $361.8M (+21.3% YoY); health plan membership 98,400 (+14.3%).
Estimated 108,300 Health Plan Members as of Jan 1, 2023, up ~17% YoY; excludes ~7,500 ACO REACH members.
Alignment Healthcare Q3 revenue up 22.8% to $360.3M; raises full-year guidance
Q3 revenue $360.3M (+22.8% YoY); health plan membership ~98,000 (+14% YoY).
Selling stockholders offer 9,000,000 shares of common stock in an underwritten offering.
Alignment Healthcare enters $250M term loan facility, repays $159.3M existing debt
Initial $165M drawn Sep 2, 2022; up to $85M delayed draw available through Sep 2027.
Alignment Healthcare Q2 revenue $366.5M (+18.6% YoY); raises FY 2022 guidance
Health plan membership 95,900, up 13.2% YoY; medical benefits ratio 83.4%, lowest since IPO.
Alignment Healthcare board sets annual say-on-pay votes after stockholder advisory vote
Stockholders voted at June 14, 2022 annual meeting to prefer annual say-on-pay votes.
Class I directors Carella, McClellan, Vorhoff elected with 148M+ votes each; broker non-votes 15.7M.
Alignment Healthcare beats Q1 guidance; revenue up 29.4% to $345.5M
Total revenue $345.5M, up 29.4% YoY; health plan premium revenue $330.9M, up 25%.
Alignment Healthcare President & CBO Rajesh Shrestha to depart April 1, 2022
Rajesh Shrestha's employment as President, New Markets and CBO terminated effective April 1, 2022; no disagreement cited.
Alignment Healthcare Q4 revenue $298.3M (+23%), net loss $47.8M; guides FY2022
Q4 2021 revenue $298.3M, +23% YoY; health plan membership 86,100, +26%.
Alignment Healthcare appoints Bilney to NCGC Committee, Jorden to Audit Committee
Board appointed Jody Bilney to NCGC Committee effective Feb 25, 2022.
Q4 2021 inpatient utilization estimated at ~155 admissions per thousand, ~5% better than November 4 guidance.
Alignment Healthcare adds two independent directors, expanding board to 11 members
Jody Bilney (ex-Humana chief consumer officer) and Yon Yoon Jorden (CFO of four public companies) elected to board effective Jan 1, 2022.
Alignment Healthcare Q3 revenue $293.5M (+18% YoY); net loss $45.8M vs profit year ago
Health plan membership ~86,000, up 29% YoY; medical benefit ratio 85.7% vs 76.7% in Q3 2020.
On April 9, 2025, Hakan Kardes, Chief Experience Officer of Alignment Healthcare, Inc. (the “Company”), notified the Company of his intention to resign his employment with the Company to pursue other professional opportunities.
On January 13, 2025, Alignment Healthcare, Inc. (the “Company”) announced that Dawn Maroney has been promoted to President of the Company, effective immediately
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
Pursuant to the Amendment, Mr. Konowiecki will no longer serve in an executive role leading strategic network and business development (the "Executive Role"), effective as of December 31, 2023
On September 6, 2023, Alignment Healthcare, Inc. (the “Company”) announced that Hyong (Ken) Kim, M.D., will serve as its Chief Medical Officer, effective as of September 25, 2023.
On August 9, 2023, Alignment Healthcare, Inc. (the "Company") and Dr. Dinesh Kumar reached a mutual agreement of employment separation, pursuant to which Dr. Kumar will no longer serve as the Company’s Chief Medical and Operating Officer, effective as of October 1, 2023 (the “Effective Date”).
On July 11, 2023, Mr. Richard Cross, Senior Vice President, General Counsel and Corporate Secretary of Alignment Healthcare, Inc. (the “Company”), informed the Company that he plans to retire from his position effective as of September 1, 2023 (the “Effective Date”).
mutually agreed to terminate his employment as President, New Markets and Chief Business Officer of the Company, effective as of April 1, 2022.
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.
Max materiality 0.90 · Median 0.60 · Most common event earnings